ARTICLE | Company News
PerSeptive deal
March 4, 1996 8:00 AM UTC
PBIO's shareholders approved the acquisition of PerSeptive Technologies II (PTCCZ), which PBIO formed in 1993 to conduct R&D for diagnostics, sequencing technologies and peptide synthesis (see BioCent...